Angioklinika - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 6,864 | 23,919 | 17,908 | 54,346 | 58,818 | 49,266 | 92,700 | 129,594 |
| Profit before tax | -1,088 | 13,747 | 5,282 | - | - | 12,614 | 14,838 | 43,350 |
| Net profit | -1,088 | 13,625 | 5,018 | 19,526 | 4,913 | 11,971 | 14,092 | 40,778 |
| Equity | -11,305 | 2,320 | 47,339 | 26,865 | 31,393 | 19,451 | 21,398 | 26,503 |
| Liabilities | - | - | - | 64,219 | 1,649 | 2,049 | 2,612 | 4,588 |
| Non-current assets | 2,986 | 2,669 | 45,705 | 71,668 | 22,867 | 17,627 | 13,300 | 8,169 |
| Current assets | 1,619 | 1,781 | 5,197 | 19,037 | 10,175 | 3,586 | 10,311 | 1,181 |
| Total assets | 4,605 | 4,450 | 50,902 | 90,705 | 33,042 | 21,213 | 23,611 | 9,350 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 4,652 | 4,021 | 12,369 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | +248.5% | -25.1% | +203.5% | +8.2% | -16.2% | +88.2% | +39.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -23.6% | 306.2% | 9.9% | 21.5% | 14.9% | 56.4% | 59.7% | 436.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | 587.3% | 10.6% | 72.7% | 15.6% | 61.5% | 65.9% | 153.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -15.9% | 57.0% | 28.0% | 35.9% | 8.4% | 24.3% | 15.2% | 31.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -15.9% | 57.5% | 29.5% | - | - | 25.6% | 16.0% | 33.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | 2.4 | 0.1 | 0.1 | 0.1 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Angioklinika - Social security debts
The company had no debts to Sodra
Angioklinika - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-08-07 | 2025-08-07 | 3154.41 |
| 2025-04-24 | 2025-04-28 | 1006.9 |
| 2025-01-31 | 2025-02-02 | 2.88 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Angioklinika, MB (code 304686076) is a Lithuanian small partnership engaged in medical specialists activities. In the latest financial year 2025, the company generated revenue of €129.6K and net profit of €40.8K, which corresponds to a profit margin of 31.5%. Revenue increased by 39.8% year on year, while the two-year revenue growth reached 163.1%, showing a strong upward trajectory. Profitability also improved materially in 2025 after a more moderate result in 2024, when revenue was €92.7K and net profit €14.1K, compared with €49.3K revenue and €12.0K net profit in 2023. On the balance sheet, total assets stood at €9.3K at the end of 2025, with equity of €26.5K and liabilities of €4.6K. The reported figures indicate a business with growing sales and stronger earnings in 2025, supported by a small balance sheet base.